GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » LT-Debt-to-Total-Asset

Feedback (LSE:FDBK) LT-Debt-to-Total-Asset : 0.00 (As of Nov. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Feedback LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Feedback's long-term debt to total assests ratio for the quarter that ended in Nov. 2023 was 0.00.

Feedback's long-term debt to total assets ratio stayed the same from Nov. 2022 (0.00) to Nov. 2023 (0.00).


Feedback LT-Debt-to-Total-Asset Historical Data

The historical data trend for Feedback's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feedback LT-Debt-to-Total-Asset Chart

Feedback Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Feedback Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Feedback LT-Debt-to-Total-Asset Calculation

Feedback's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in May. 2023 is calculated as

LT Debt to Total Assets (A: May. 2023 )=Long-Term Debt & Capital Lease Obligation (A: May. 2023 )/Total Assets (A: May. 2023 )
=0/11.724
=0.00

Feedback's Long-Term Debt to Total Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

LT Debt to Total Assets (Q: Nov. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Nov. 2023 )/Total Assets (Q: Nov. 2023 )
=0/9.883
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feedback  (LSE:FDBK) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Feedback LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Feedback's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Feedback (LSE:FDBK) Business Description

Traded in Other Exchanges
N/A
Address
3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.

Feedback (LSE:FDBK) Headlines

No Headlines